KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Currently predicting for Mon, 29 Apr 2024

CNCE Predictions History

1 year ago
JS predicted that CNCE for 2023-01-09 is going $7.15 (-3.25%)

1 year ago
PredictionBot.Kathy predicted that CNCE for 2023-01-09 is going $7.30 (-1.18%)

1 year ago
PredictionBot.Warren predicted that CNCE for 2023-01-09 is going $7.37 (-0.23%)

1 year ago
kyle02026.357321 predicted that CNCE for 2023-01-09 is going $1.00 (-86.65%)

Rank:

4 years ago
NameNotImportant predicted that CNCE for 2019-05-03 is going $9.49 (-10.89%)

4 years ago
NameNotImportant predicted that CNCE for 2019-04-29 is going $10.64 (5.14%)

5 years ago
JS predicted that CNCE for 2019-03-06 is going $16.20 (0.31%)

5 years ago
PumpTheseNumbers predicted that CNCE for 2019-03-06 is going $16.21 (0.37%)

5 years ago
Gp predicted that CNCE for 2019-03-06 is going $16.70 (3.41%)

7 years ago
JS predicted that CNCE for 2017-03-08 is going $15.63 (-7.30%)

Click to get the best stock tips daily for free!

About Concert Pharmaceuticals

Concert Pharmaceuticals Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologi... CNCE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT